The discovery, detailed in a study in Current Biology, could inform a key strategy to protect the food supply in the face of climate instability, the researchers said. Agricultural productivity is ...
Mesoblast shares are in focus after reaching a major patient recruitment milestone in its pivotal Phase 3 trial for chronic low back pain. Mesoblast's Phase 3 trial is evaluating a single intra-discal ...
MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE)-- RenovoRx, Inc. ("RenovoRx” or "the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and ...
Paradigm Biopharmaceuticals (ASX: PAR) has completed enrolment in its pivotal Phase 3 clinical trial evaluating Zilosul for ...
GRI Bio, Inc. has announced expected interim and topline data readouts from its Phase 2a biomarker study for the lead program GRI-0621, aimed at treating idiopathic pulmonary fibrosis (IPF), in Q2 and ...
The Mesoblast Ltd (ASX: MSB) share price is in focus after the company announced it has reached its patient recruitment target in its pivotal Phase 3 trial for chronic low back pain. This milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results